MedTrace Logo

RWE Study Utilizing the Cala Trio Device in Patients With Essential Tremor

NCT05540626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276

Last updated 2025-05-07

No results posted yet for this study

Summary

The study objective is to evaluate hand tremor relief in the treated hand following stimulation with the Cala Trio Device in adults with essential tremor, and healthcare resource utilization and total healthcare costs over a 12-month period.

Conditions

Interventions

DEVICE

Cala Trio

transcutaneous afferent patterned stimulation (TAPS)

Sponsors & Collaborators

  • CVS Healthspire Life Sciences Solutions

    collaborator UNKNOWN

  • Cala Health, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-08
Primary Completion
2024-03-01
Completion
2024-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540626 on ClinicalTrials.gov